Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
15.03
-0.06 (-0.40%)
At close: Aug 13, 2026, 4:00 PM EDT
15.13
+0.10 (0.67%)
Pre-market: Aug 14, 2026, 5:41 AM EDT
Generate Biomedicines Earnings Call Transcripts
Fiscal Year 2026
-
The platform integrates advanced computational and experimental methods to accelerate novel protein drug discovery, with a lead anti-TSLP antibody in phase III for severe asthma and a robust oncology pipeline. Strategic partnerships and a focus on biannual dosing aim to improve compliance and market impact.